Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | BMY | AMGN | GILD | REGN |
| Company | Ultragenyx Pharmaceu | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 45.52 | 49.00 | 270.63 | 66.58 | 906.90 |
| High | 45.55 | 49.04 | 274.86 | 67.18 | 915.70 |
| Low | 43.61 | 48.55 | 269.64 | 66.36 | 904.41 |
| Last | 44.28 | 48.86 | 273.01 | 67.08 | 906.54 |
| Change | -0.83 | -0.13 | -0.53 | +0.05 | -0.78 |
| % Change | -1.84% | -0.27% | -0.19% | +0.07% | -0.09% |
| Volume | 670,632 | 16,051,517 | 2,465,818 | 8,464,430 | 373,548 |
| 20-Day Average Volume | 735,742 | 11,258,831 | 2,172,641 | 6,490,406 | 441,812 |
| Previous Close | 45.11 | 48.99 | 273.54 | 67.03 | 907.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.48 | 50.37 | 271.55 | 69.07 | 926.29 |
| 20-Day Raw Stochastic | 27.94% | 18.15% | 44.22% | 14.81% | 18.66% |
| 20-Day Relative Strength | 44.67% | 41.15% | 48.18% | 33.12% | 39.46% |
| Weighted Alpha | +2.04 | -26.02 | +11.15 | -20.78 | +13.86 |
| Today's Opinion | 24% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 24% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 56% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 04/17/24 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +0.59% since 04/17/24 |
| Low | 41.07 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 45.58 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -3.42% since 03/22/24 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -6.28% since 03/22/24 |
| Low | 41.07 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 52.56 on 04/11/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +1.54% since 01/24/24 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -4.40% since 01/24/24 |
| Low | 41.07 on 04/19/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 54.56 on 03/01/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +37.60% since 10/24/23 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +12.71% since 10/24/23 |
| Low | 31.62 on 10/25/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 54.56 on 03/01/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,712,553 | 99,290,928 | 146,720,288 | 83,457,512 | 99,589,264 |
| Shares Outstanding, K | 82,300 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 434,250,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -606,640,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 127,390,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -123,190,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.65 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.52 on 02/15/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 23.95 |